Administration of aspirin-dipyridamole reduces proteinuria in diabetic nephropathy.
Explore this paper's citation graph
Summary
The results showed that this treatment significantly reduced proteinuria in patients with diabetic nephropathy, and the mechanism of action was not entirely clear.
- Type
- article
- Published
- 1989-01-01
- Cited by
- 28
- References
- 0
- OpenAlex
- https://openalex.org/W1868700285
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:34919152
Keywords
Medicine, Dipyridamole, Renal function, Aspirin, Diabetic nephropathy
References
No references recorded for this paper.
Cited by
- Time for a comeback of NSAIDs in proteinuric chronic kidney disease?
- Influence of Blood Pressure Level on the Suppression of Proteinuria by Dipyridamole in Diabetic Patients with Nephropathy
- Adenosine signalling in diabetes mellitus—pathophysiology and therapeutic considerations
- Implications of Treatment That Target Protective Mechanisms Against Diabetic Nephropathy
- Targeting inflammation in diabetes: Newer therapeutic options.
- Present and Future in the Treatment of Diabetic Kidney Disease
- Classical and pleiotropic actions of dipyridamole: Not enough light to illuminate the dark tunnel?
- Therapeutic uses of aspirin in renal diseases.
- Inflammation and Oxidative Stress in Diabetic Nephropathy: New Insights on Its Inhibition as New Therapeutic Targets
- Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats.
- Diabetic nephropathy: new directions in management.
- Effects of short-term treatment with naproxen on kidney function in insulin-dependent diabetic patients with microalbuminuria.
- Impact of low-dose acetylsalicylic acid on kidney function in type 2 diabetic patients with elevated urinary albumin excretion rate.
- Review: Diabetes as a procoagulant condition
- Nephrology, dialysis and transplantation.
- A Comparative Randomized and Placebo-controlled Short-term Trial of Aspirin and Dipyridamole for Overt Type-2 Diabetic Nephropathy
- Lack of impact of low-dose acetylsalicylic acid on kidney function in type 1 diabetic patients with microalbuminuria.
- SUPPRESSION OF THE NITRIC OXIDE PATHWAY IN METASTATIC RENAL CELL CARCINOMA PATIENTS RECEIVING VEGF-SIGNALING INHIBITORS
- Antioxidant and antithrombotic therapies for diabetic kidney disease.
- Is Long-Term Low-Dose Aspirin Therapy Associated with Renal Dysfunction in Patients with Type 2 Diabetes? JPAD2 Cohort Study
Related papers
- Renogram deconvolution in the management of diabetic nephropathy: utility of the measurement of initial tracer uptake.
- Effect of blood pressure on diabetic nephropathy
- Decline of Renal Function Is Associated with Proteinuria and Systolic Blood Pressure in the Morning in Diabetic Nephropathy
- Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers
- Effect of enalapril and losartan on proteinuria in type 2 diabetic nephropathy patients.
- A Comparative Randomized and Placebo-controlled Short-term Trial of Aspirin and Dipyridamole for Overt Type-2 Diabetic Nephropathy
- Study of diabetes mellitus nephropathy diagnosed with radionuclide renal dynamic imaging
- Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes